bcx 1812 has been researched along with foscarnet in 1 studies
| Studies (bcx 1812) | Trials (bcx 1812) | Recent Studies (post-2010) (bcx 1812) | Studies (foscarnet) | Trials (foscarnet) | Recent Studies (post-2010) (foscarnet) |
|---|---|---|---|---|---|
| 25 | 1 | 12 | 1,682 | 116 | 257 |
| Protein | Taxonomy | bcx 1812 (IC50) | foscarnet (IC50) |
|---|---|---|---|
| DNA polymerase catalytic subunit | Human herpesvirus 5 strain AD169 | 2.5 | |
| DNA polymerase catalytic subunit | Human herpesvirus 3 strain Dumas | 0.28 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 2.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
1 other study(ies) available for bcx 1812 and foscarnet
| Article | Year |
|---|---|
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |